Welcome to LookChem.com Sign In|Join Free

CAS

  • or

139-85-5

Post Buying Request

139-85-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

139-85-5 Usage

Description

Protocatechualdehyde is extracted from roots of the common traditional Chinese medicine Salvia miltiorrhiza Bge, which was harvested in autumn for better quality. Take root and remove stems, leaves and fibrous roots, then dry it. Most of them are wide, and they are mainly cultivated in recent years. South Salvia and Gansu Salvia are also widely used. Besides, there are a variety of sibling plant roots used as Salvia miltiorrhiza in Yunnan. Now, the existence of protocatechualdehyde has been found in variety of herbs, for example, in the leaf of Stenoloma Chusanum (L.) Ching and Ilex chinensis Sims.

Chemical Properties

Protocatechualdehyde is a phenolic aldehyde crystalline compound with the molecular formula C7H6O3. The compound is released from cork stoppers into wine. protocatechualdehyde can be found in barley, grapevine, green Cavendish, and root of herb S. miltiorrhiza. The compound contains pro-apoptotic and antiproliferative properties against human breast cancer cells as well as colorectal cancer cells by reducing the expression of cyclin D1 and β-catenin.

Physical properties

Appearance: pale beige acicular crystal (in water or methylbenzene) or off-white powder, crystal twin shape. Solubility: easily soluble in ethanol, acetone, ethyl acetate, ethyl ether, and hot water; soluble in cold water; insoluble in benzene and chloroform. Melting point: 150–153?°C. Specific optical rotation: easily oxidized to benzoquinone and changes color, and it is instable in water.

History

In the 1940s, the research was conducted overseas to obtain protocatechualdehyde form herbs. In 1972, the chemical group of Chinese herbal medicine in Nanjing College of Pharmacy systematically studied chemical composition in purple flower holly leaf and separated six monomers including protocatechualdehyde. Then they compared the effect of protocatechualdehyde, Salvia miltiorrhiza injection and hairy holly root injection, in which protocatechualdehyde is the most effective in increasing coronary sinus flow. Further experiments examined that protocatechualdehyde can increase coronary flow and improve coronary circulation, so it was called after perhexiline. Further clinical observation indicated that protocatechualdehyde has effect on coronary heart disease. The graduates of Nanjing College of Pharmacy in 1975 extracted, separated, isolated, and identified protocatechualdehyde in Salviamiltiorrhiza during the internship in Nanjing Municipal Hospital and studied its distribution, excretion, and toxicity in animals for clinical rational drug usage

Uses

Different sources of media describe the Uses of 139-85-5 differently. You can refer to the following data:
1. 3,4-Dihydroxybenzaldehyde is used in as an apoptosis inducer of human leukemia cells.
2. 3,4-Dihydroxybenzaldehyde may be used for the surface modification of nanocrystalline TiO2 particles. Electrodeposited layer of 3,4-dihydroxybenzaldehyde may be used as effective redox mediator during oxidation of NADH at graphene. It may be used in the preparation of new diSchiff base ligands, which forms di-, tri- and tetranuclear Co(II) and Cu(II) complexes.

Synthesis Reference(s)

The Journal of Organic Chemistry, 27, p. 2037, 1962 DOI: 10.1021/jo01053a030

General Description

3,4-Dihydroxybenzaldehyde has been recognized as one of the antifungal compound extracted from the outer skin of green Cavendish bananas. It can be synthesized from catechol via Fries rearrangement.

Pharmacology

Protection of?Myocardial Cells and?Myocardial Ischemia Reducing Ca2+ concentration in adult erythrocyte cytosolic to protect the myocardium, dilating the coronary arteriae, promoting collateral circulation, increasing myocardial oxygen supply coronary blood flow, improving collateral circulation without increasing the ventricular and myocardial oxygen consumption, decreasing heart rate, inhibiting myocardial contractility, expanding peripheral vascular, and ultimately reducing cardiac load and myocardial oxygen consumption. Used for the treatment of coronary heart disease and angina pectoris. Effects on?Atherosclerosis Protocatechualdehyde improves atherosclerosis from the effect of inhibition of inflammation, apoptosis, and leukocyte chemotaxis. Antithrombotic Effects 1. Platelet aggregation inhibition: Administration of protocatechualdehyde in?vitro and in?vivo has apparently effect on inhibiting platelet aggregation induced by ADP.?Protocatechualdehyde 0.625, 1.25, and 2.5?mg/ml can decrease the degree and slow down the rate of platelet aggregation and promote the aggregation of platelet. 2. Improving microcirculation: Protocatechualdehyde can increase the blood flow of microcirculation, accelerate the flow of blood to improve the oxygen supply of cells, and reduce the number of normal red cells to spiny red cells and the abnormal shape of spiny red cells. Antioxidation Effects Protocatechualdehyde contains phenolic hydroxyl in ortho-position, which is material base for its antioxidation. It has good activities for scavenging free radical. So it treats cardiovascular and cerebrovascular diseases induced by active oxygen. Protection of?Nerve Cells and?Cerebral Ischemia Injury Protection of cerebral ischemia injury might be concerned with reducing the production of TXA2?in brain tissue, inhibiting the release of excitatory amino acids in brain tissue, and improving the microcirculation of brain tissue. Repair of?Damaged Venous Valve and?Treatment of?Phlebeurysm Protocatechualdehyde reduced the fibrosis of tissues and organs effectively, dissolved fibrin, promoted the regeneration of fibrotic cells, and repaired damaged venous valves to prevent flowing back of blood and cure phlebeurysm effectively. Other Effects Protecting the liver and promoting repair and regeneration of liver tissue; antifibrosis of liver and promoting the healing of fracture and wounds; antibacterial, anti-inflammatory, antiviral, anti-sepsis, and preventing pigmentation.

Clinical Use

Perhexiline injection containing protocatechualdehyde 100? mg/2? mL by intravenous infusion or intramuscular injection was used to treat coronary heart disease, chest tightness, angina, and myocardial infarction. Injection treats ischemic stroke and improves both symptoms and signs of patients. Treating chronic hepatitis and early cirrhosis: relieving the symptoms, promoting the recovery of liver function, and hepatosplenomegaly. It can significantly improve the blood rheology index for patients with acute exacerbation of chronic pulmonary heart disease. Treatment of peptic ulcer: a certain effect. Others: it has effect on many diseases like viral myocarditis, embolism of central retinal artery, thromboangiitis obliterans, scleredema neonatorum, scleroderma, psoriasis, nerve deafness, and toxemia of pregnancy.

Enzyme inhibitor

This aldehyde (FW = 138.12 g/mol), also known as 3,4- dihydroxybenzaldehyde and 4-formylcatechol, is soluble in water (5 g/100 mL at 20°C) and has a pKa value of 7.55 at 25°C. Protocatechualdehyde induces apoptosis in cytotoxic T cells. Target(s): aldehyde oxidase; aldose reductase; b-carotene 15,15’-monooxygenase; mandelonitrile lyase; protocatechuate 3,4-dioxygenase; protocatechuate 4,5- dioxygenase; tyrosinase, weakly inhibited, IC50 = 620 μM; and xanthine oxidase.

Purification Methods

Crystallise the aldehyde from water or toluene and dry it in a vacuum desiccator over KOH pellets or shredded wax respectively. [Beilstein 8 IV 1762.]

Check Digit Verification of cas no

The CAS Registry Mumber 139-85-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,3 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 139-85:
(5*1)+(4*3)+(3*9)+(2*8)+(1*5)=65
65 % 10 = 5
So 139-85-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H6O3/c8-4-5-1-2-6(9)7(10)3-5/h1-4,9-10H

139-85-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A11558)  3,4-Dihydroxybenzaldehyde, 98%   

  • 139-85-5

  • 5g

  • 498.0CNY

  • Detail
  • Alfa Aesar

  • (A11558)  3,4-Dihydroxybenzaldehyde, 98%   

  • 139-85-5

  • 25g

  • 1226.0CNY

  • Detail
  • Alfa Aesar

  • (A11558)  3,4-Dihydroxybenzaldehyde, 98%   

  • 139-85-5

  • 100g

  • 3397.0CNY

  • Detail

139-85-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-dihydroxybenzaldehyde

1.2 Other means of identification

Product number -
Other names Benzaldehyde, 3,4-dihydroxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:139-85-5 SDS

139-85-5Synthetic route

vanillin
121-33-5

vanillin

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With boron tribromide In dichloromethane at 4℃; for 1h;100%
With boron tribromide-dimethyl sulfide complex In 1,2-dichloro-ethane at 83.5℃; for 0.1h;99.3%
Stage #1: vanillin With boron tribromide-dimethyl sulfide complex In dichloromethane at 0 - 20℃; Inert atmosphere;
Stage #2: With water In methanol; dichloromethane at 0℃; for 0.166667h; Inert atmosphere;
99%
isovanillin
621-59-0

isovanillin

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
Stage #1: isovanillin With pyridine; iodine; aluminium In acetonitrile for 18h; Reflux;
Stage #2: With hydrogenchloride In water; acetonitrile at 20℃;
99%
With aluminium(III) iodide In dimethyl sulfoxide; acetonitrile at 80℃; for 18h;95%
With aluminium(III) iodide; dimethyl sulfoxide In acetonitrile at 80℃; for 18h;95%
piperonal
120-57-0

piperonal

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With boron trichloride - methyl sulfide complex In 1,2-dichloro-ethane at 83.5℃; for 29.5h; other reagent;98.5%
With aluminium(III) iodide; tetra-(n-butyl)ammonium iodide In cyclohexane for 1.5h; Heating;84%
With titanium tetrachloride In dichloromethane at -20 - -10℃; for 4h; Inert atmosphere;68.4%
3,4-bis-methoxymethoxy-benzaldehyde
6515-06-6

3,4-bis-methoxymethoxy-benzaldehyde

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With toluene-4-sulfonic acid In neat (no solvent, solid phase) at 20℃; for 0.583333h; Green chemistry;98%
2-iodoisovanillin
138490-94-5

2-iodoisovanillin

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
In [(2)H6]acetone; dichloromethane96.1%
4-hydroxy-3-ethoxybenzaldehyde
121-32-4

4-hydroxy-3-ethoxybenzaldehyde

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With aluminium(III) iodide In dimethyl sulfoxide; acetonitrile at 80℃; for 18h;96%
With aluminium(III) iodide; dimethyl sulfoxide In acetonitrile at 80℃; for 18h;95%
With aluminium(III) iodide; calcium oxide In acetonitrile at 80℃; for 18h;93%
3,4-dihydroxyphenylacetate
102-32-9

3,4-dihydroxyphenylacetate

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With dipotassium peroxodisulfate In water at 90℃; for 12h; Green chemistry;63%
benzene-1,2-diol
120-80-9

benzene-1,2-diol

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
62.4%
3,4-dimethoxy-benzaldehyde
120-14-9

3,4-dimethoxy-benzaldehyde

A

vanillin
121-33-5

vanillin

B

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With 1-methyl-pyrrolidin-2-one; potassium carbonate; thiophenol for 0.25h; Heating;A 58%
B 20%
3-hydroxy-4-methoxybenzyl alcohol
4383-06-6

3-hydroxy-4-methoxybenzyl alcohol

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
Stage #1: 3-hydroxy-4-methoxybenzyl alcohol With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In tetrahydrofuran at 20℃; Darkness;
Stage #2: With sodium dithionite; water In tetrahydrofuran Darkness;
56%
3,4-dihydroxy-5-iodobenzaldehyde
54246-05-8

3,4-dihydroxy-5-iodobenzaldehyde

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With silver; sodium hydrogencarbonate; sodium iodide; zinc In 1,2-dimethoxyethane; dimethyl sulfoxide at 80℃; for 6h;27%
methanol
67-56-1

methanol

caffeic acid
331-39-5

caffeic acid

A

3,4-Dihydroxybenzoic acid
99-50-3

3,4-Dihydroxybenzoic acid

B

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

C

(E)-2-hydroxy-2-(3,4-dihydroxyphenyl)ethanaloxime

(E)-2-hydroxy-2-(3,4-dihydroxyphenyl)ethanaloxime

D

(E)-2-(3,4-dihydroxyphenyl)-2-methoxyethanaloxime

(E)-2-(3,4-dihydroxyphenyl)-2-methoxyethanaloxime

Conditions
ConditionsYield
With acetate buffer; sodium nitrite at 20℃; for 4h; pH=4; Further byproducts.;A 6%
B 9%
C 10%
D 5%
D-erythrose
583-50-6

D-erythrose

A

5-hydroxymethyl-2-furfuraldehyde
67-47-0

5-hydroxymethyl-2-furfuraldehyde

B

3,4-Dihydroxybenzoic acid
99-50-3

3,4-Dihydroxybenzoic acid

C

1-(3,4-dihydroxyphenyl)ethan-1-one
1197-09-7

1-(3,4-dihydroxyphenyl)ethan-1-one

D

1-[5-(hydroxymethyl)furan-2-yl]ethan-1-one
55087-82-6

1-[5-(hydroxymethyl)furan-2-yl]ethan-1-one

E

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

F

3-methylbenzene-1,2-diol
488-17-5

3-methylbenzene-1,2-diol

Conditions
ConditionsYield
With acetate buffer for 45h; Product distribution; Heating;A 0.04%
B 0.03%
C 0.01%
D 0.15%
E 0.01%
F 0.03%
methanol
67-56-1

methanol

4-benzenesulfonyloxy-3-hydroxy-benzaldehyde

4-benzenesulfonyloxy-3-hydroxy-benzaldehyde

sodium methylate
124-41-4

sodium methylate

A

vanillin
121-33-5

vanillin

B

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

N-Bromosuccinimide
128-08-5

N-Bromosuccinimide

piperonal
120-57-0

piperonal

chloroform
67-66-3

chloroform

A

6-bromopiperonylic acid
60546-62-5

6-bromopiperonylic acid

B

6-bromo-3,4-methylenedioxybenzaldehyde
15930-53-7

6-bromo-3,4-methylenedioxybenzaldehyde

C

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
auch unter Zusatz von Dibenzoylperoxid;
5-dichloromethyl-benzo[1,3]dioxol-2-one
866998-51-8

5-dichloromethyl-benzo[1,3]dioxol-2-one

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With water
With diluted acids
1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

3-bromo-4-hydroxybenzylaldehyde
2973-78-6

3-bromo-4-hydroxybenzylaldehyde

A

3,4-Dihydroxybenzoic acid
99-50-3

3,4-Dihydroxybenzoic acid

B

4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

C

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

D

4-hydroxy-benzoic acid
99-96-7

4-hydroxy-benzoic acid

Conditions
ConditionsYield
at 160℃;
at 190℃;
4-hydroxy-3-(methoxymethoxy)benzaldehyde
65298-98-8

4-hydroxy-3-(methoxymethoxy)benzaldehyde

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With sodium hydrogensulfite und anschliessendes Erhitzen mit wss.H2SO4;
With methanol; mineral acid
hexamethylenetetramine
100-97-0

hexamethylenetetramine

benzene-1,2-diol
120-80-9

benzene-1,2-diol

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With p-dimethylaminonitrosobenzene
5-formyl-2-hydroxybenzaldehyde
3328-70-9

5-formyl-2-hydroxybenzaldehyde

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
With sodium hydroxide; dihydrogen peroxide
3-bromo-4-hydroxybenzylaldehyde
2973-78-6

3-bromo-4-hydroxybenzylaldehyde

furan-2,3,5(4H)-trione pyridine (1:1)

furan-2,3,5(4H)-trione pyridine (1:1)

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

Conditions
ConditionsYield
at 150 - 200℃; unter Druck;
benzyl chloride
100-44-7

benzyl chloride

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 15h;100%
With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 15h;99%
With potassium carbonate In N,N-dimethyl-formamide at 20 - 130℃; for 4h;96%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-bis(tert-butyldimethylsilanyloxy)benzaldehyde
99815-16-4

3,4-bis(tert-butyldimethylsilanyloxy)benzaldehyde

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide100%
With 1H-imidazole; dmap In N,N-dimethyl-formamide at 20℃; for 1h;99%
With 1H-imidazole In dichloromethane98%
1-bromo dodecane
112-29-8

1-bromo dodecane

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-didecyloxybenzaldehyde
118468-34-1

3,4-didecyloxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 20h; Williamson ether synthesis;100%
With potassium carbonate; potassium iodide In dichloromethane at 90℃; for 16h; Inert atmosphere;97%
Stage #1: 3,4-dihydroxybenzaldehyde With potassium carbonate In N,N-dimethyl-formamide for 0.166667h;
Stage #2: 1-bromo dodecane In N,N-dimethyl-formamide at 100℃; for 12h;
91%
allyl bromide
106-95-6

allyl bromide

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-diallyloxybenzaldehyde
71186-67-9

3,4-diallyloxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;100%
With potassium carbonate; sodium iodide In N,N-dimethyl-formamide at 60℃; for 2h;98%
With potassium carbonate; sodium iodide In N,N-dimethyl-formamide at 60℃; for 2h;98%
3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-dihydroxybenzonitrile
17345-61-8

3,4-dihydroxybenzonitrile

Conditions
ConditionsYield
With hydroxylamine hydrochloride In 1-methyl-pyrrolidin-2-one at 100℃; for 0.5h;100%
With 1-methyl-pyrrolidin-2-one; hydroxylamine hydrochloride at 100℃; for 0.25h; Condensation; microwave irradiation;89%
With formic acid; hydroxylamine hydrochloride; silica gel for 0.0166667h; Irradiation;70 % Chromat.
1,3,5-tris(3-aminopropyl)adamantane
1029302-64-4

1,3,5-tris(3-aminopropyl)adamantane

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

N,N′,N′′-tris(3,4-dihydroxybenzylidene)adamantane-1,3,5-tripropaneamine
1448150-60-4

N,N′,N′′-tris(3,4-dihydroxybenzylidene)adamantane-1,3,5-tripropaneamine

Conditions
ConditionsYield
In ethanol for 24h; Inert atmosphere;100%
dimedone
126-81-8

dimedone

malononitrile
109-77-3

malononitrile

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

2-amino-4-(3,4-dihydroxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
326918-69-8

2-amino-4-(3,4-dihydroxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

Conditions
ConditionsYield
With horsetail plant ash In neat (no solvent) at 20℃; for 0.25h; Catalytic behavior; Reagent/catalyst;100%
With 1,4-diaza-bicyclo[2.2.2]octane In 1,4-dioxane for 1.5h; Reflux;97%
With 1-methylimidazolium tricyanomethanide In neat (no solvent) at 20℃; for 0.333333h; Green chemistry;92%
With potassium carbonate In water at 20℃; for 1.16667h; Green chemistry;82%
With dmap at 150℃; for 0.333333h; Microwave irradiation;57%
hydrogen cyanide
74-90-8

hydrogen cyanide

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

(R)-3,4-dihydroxymandelonitrile
190383-25-6

(R)-3,4-dihydroxymandelonitrile

Conditions
ConditionsYield
With (R)-hydroxynitrile lyase from Prunus amygdalus turcomanica Lincz immobilized onto Eupergit CM In tert-butyl methyl ether; dimethyl sulfoxide at 5℃; for 72h; pH=4; Reagent/catalyst; Enzymatic reaction; enantioselective reaction;100%
ethyl acetoacetate
141-97-9

ethyl acetoacetate

malononitrile
109-77-3

malononitrile

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

6-amino-1,4-dihydro-4-(3,4-dihydroxyphenyl)-3methyl-pyran [2,3-c]pyrazole-5-carbonitrile

6-amino-1,4-dihydro-4-(3,4-dihydroxyphenyl)-3methyl-pyran [2,3-c]pyrazole-5-carbonitrile

Conditions
ConditionsYield
Stage #1: ethyl acetoacetate With hydrazine hydrate; C10H21N2(1+)*C2H3O2(1-) at 60℃; for 0.0833333h;
Stage #2: malononitrile; 3,4-dihydroxybenzaldehyde In acetonitrile at 20 - 25℃; for 0.5h; Reagent/catalyst; Temperature;
100%
With hydrazine hydrate In ethanol; water for 0.666667h; Reflux; Green chemistry;82%
3-[2-(4-hydroxyphenyl)ethyl]-2-thioxo-1,3-thiazolidin-4-one

3-[2-(4-hydroxyphenyl)ethyl]-2-thioxo-1,3-thiazolidin-4-one

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

5-(3,4-dihydroxybenzylidene)-3-[2-(4-hydroxyphenyl)ethyl]-2-thioxothiazolidine-4-one

5-(3,4-dihydroxybenzylidene)-3-[2-(4-hydroxyphenyl)ethyl]-2-thioxothiazolidine-4-one

Conditions
ConditionsYield
With ammonium acetate; acetic acid Reflux;100%
BARBITURIC ACID
67-52-7

BARBITURIC ACID

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

5-(3,4-dihydroxybenzylidene)-2,4,6(1H,3H,5H)-pyrimidinetrione
191167-05-2

5-(3,4-dihydroxybenzylidene)-2,4,6(1H,3H,5H)-pyrimidinetrione

Conditions
ConditionsYield
In ethanol; water at 80℃; for 8h;99.3%
In ethanol; water at 80℃; for 8h;99.3%
With ammonium chloride In water at 20℃; for 0.5h;94%

139-85-5Related news

Protocatechualdehyde (cas 139-85-5) Protects Against Cerebral Ischemia-Reperfusion-Induced Oxidative Injury Via Protein Kinase Cε/Nrf2/HO-1 Pathway09/30/2019

Oxidative stress is closely related to the pathogenesis of ischemic stroke. Protocatechualdehyde (PCA) is a phenolic acid compound that has the putative antioxidant activities. The present study was aimed to investigate the molecular mechanisms involved in the antioxidative effect of PCA against...detailed

Synthesis, Characterization and Biological Evaluation of Fe (III), Co (II), Ni(II), Cu(II), and Zn(II) Complexes with Tetradentate Schiff Base Ligand Derived from Protocatechualdehyde (cas 139-85-5) with 2-Aminophenol09/29/2019

Schiff base ligand (H3L) was prepared from the condensation reaction of protochatechualdehyde (3,4-dihydroxybenzaldhyde)with 2-amino phenol. From the direct reaction of the ligand (H3L) with Co(II), Ni(II) and Cu(II) chlorides, and Fe(III)and Zn(II)nitrates in 2 M/1 L molar ratio, the five new n...detailed

Synergism between Protocatechualdehyde (cas 139-85-5) and rare earth cerium(IV) ion on the corrosion of cold rolled steel in hydrochloric acid solution10/01/2019

The synergism between protocatechualdehyde (PAL, 3,4‐dihydroxy‐benzaldehye) and rare earth cerium(IV) ion (Ce4+) on the corrosion of cold rolled steel (CRS) in 1.0 M hydrochloric acid (HCl) solution has been investigated by weight loss and potentiodynamic polarization methods. The results reve...detailed

139-85-5Relevant articles and documents

Electrochemically exfoliated graphene for nanosensor applications

Sivasankar,Senthilkumar,Vivekananth,Kalaivani,Sivakumar

, p. 7097 - 7104 (2019)

Water dispersible graphene layer are the excellent nano materials used for wide range of electronic applications. High quality graphene was synthesized by an eco-friendly, easy and cost effective electrochemical exfoliation method. In this work, graphite rod was used both as an anode and cathode for the production of graphene. Potassium sulphate (K2SO4) was used as an intercalating agent. Electrochemically exfoliated graphene (EEG) was coated on glassy carbon electrode (GCE) and evaluated towards the electrochemical oxidation of vanillin and L-phenylalanine. The fabricated electrode was able to detect vanillin and L-Phenylalanine as low as 0.2 μM with signal to noise ratio of 3. A significant increase in the current was observed for the graphene coated electrode for both vanillin and L-phenylalanine when compared to bare Glassy electrode. The finding clearly demonstrated the higher detection capability, selectivity and reproducibility of EEG.

Stereoselective synthesis of trans-dihydronarciclasine derivatives containing a 1,4-benzodioxane moiety

Varró, Gábor,Pogrányi, Balázs,Grün, Alajos,Simon, András,Heged?s, László,Kádas, István

, p. 2265 - 2285 (2018)

Abstract: Some new trans-dihydronarciclasine derivatives containing a 1,4-benzodioxane moiety were stereoselectively synthesised using our feasible and efficient method developed recently. These new phenanthridone alkaloid analogues were obtained in both racemic and optically active forms. High enantioselectivities (up to 99% ee) were achieved by applying (8S,9S)-9-amino(9-deoxy)epiquinine as an organocatalyst. Due to a side reaction, various methoxyphenanthridine regioisomers were also prepared which afforded further synthetic trans-dihydronarciclasine analogues modified in the ring A of the phenanthridone scaffold. Graphical abstract: [Figure not available: see fulltext.].

On the difference in decomposition of taxifolin and luteolin vs. fisetin and quercetin in aqueous media

Sokolová, Romana,Rame?ová, ?árka,Kocábová, Jana,Kolivo?ka, Viliam,Degano, Ilaria,Pitzalis, Emanuela

, p. 1375 - 1383 (2016)

Abstract: The decomposition of flavonols quercetin and fisetin, flavone luteolin and flavanone taxifolin was studied in slightly alkaline solution under ambient conditions. The study was based on spectrophotometry and high-pressure liquid chromatography. Products formed by atmospheric oxygen oxidation and hydrolysis were identified by HPLC–DAD and HPLC–ESI-MS/MS. Only small differences in the chemical structure of flavonoids resulted in extremely variable oxidation pathways and products. Oxidation of flavonols led to the formation of both a benzofuranone derivative and several open structures. On the contrary, the benzofuranone derivative was not found as a product of taxifolin and luteolin oxidative decomposition. These compounds were oxidized to their hydroxylated derivatives and typical open structures. Quercetin was not identified as a possible oxidation product of taxifolin. Graphical Abstract: [Figure not available: see fulltext.]

Efficient demethylation of aromatic methyl ethers with HCl in water

Bomon, Jeroen,Bal, Mathias,Achar, Tapas Kumar,Sergeyev, Sergey,Wu, Xian,Wambacq, Ben,Lemière, Filip,Sels, Bert F.,Maes, Bert U. W.

supporting information, p. 1995 - 2009 (2021/03/26)

A green, efficient and cheap demethylation reaction of aromatic methyl ethers with mineral acid (HCl or H2SO4) as a catalyst in high temperature pressurized water provided the corresponding aromatic alcohols (phenols, catechols, pyrogallols) in high yield. 4-Propylguaiacol was chosen as a model, given the various applications of the 4-propylcatechol reaction product. This demethylation reaction could be easily scaled and biorenewable 4-propylguaiacol from wood and clove oil could also be applied as a feedstock. Greenness of the developed methodversusstate-of-the-art demethylation reactions was assessed by performing a quantitative and qualitative Green Metrics analysis. Versatility of the method was shown on a variety of aromatic methyl ethers containing (biorenewable) substrates, yielding up to 99% of the corresponding aromatic alcohols, in most cases just requiring simple extraction as work-up.

Herbicide based on haloxyfop, flumetsulam and halosulfuron-methyl

-

, (2021/06/21)

The invention discloses a herbicide based on haloxyfop, flumetsulam and halosulfuron-methyl. The herbicide is prepared from the following raw materials in parts by weight: 1-15 parts of haloxyfop-R-methyl, 1-15 parts of flumetsulam, 1-37 parts of halosulfuron-methyl, 1-2 parts of a modified antioxidant, 10-12 parts of borax, 6-8 parts of a surfactant, 10-12 parts of triethanolamine, 10-12 parts of vegetable oil and 40-42 parts of deionized water. After the haloxyfop-R-methyl, the flumetsulam and the halosulfuron-methyl are mixed, the effects are complementary, the weeding spectrum is wider, the weeding activity is high, the weeding effect is more excellent. In addition, the modified antioxidant is added into the herbicide formula, so that the composite herbicide has the effects of resisting oxidation aging and ultraviolet aging, effective components are prevented from decomposing and losing efficacy in the presence of light, the pesticide effect is kept lasting, and the application prospect and popularization value are remarkably improved.

A synthetic preparation method for small carbags hydrochloric acid

-

Paragraph 0191-0193, (2021/12/08)

The present invention belongs to the field of organic chemistry, relates to a method of synthesizing berberine hydrochloride, comprising: S1: with 5-halo-o-quinoastearaldehyde and piperine ethylamine to obtain N- [2-(3,4-dimethoxyphenyl-5-yl) ethyl] -1- (5-halo-2,3-dimethoxybenzyl) methylimide; S2: to obtain 2- (3,4-diimoxyphenyl) -N- (5-bromo-2,3-dimethoxybenzyl) ethylamine; S3: to obtain 2-(3,4-dimethoxyphenyl) -N- (5-bromo-2 S4: to obtain 12-halogenated berberine derivative; S5: to obtain berberine. The present invention is free from the application of the by-product o-vanillin synthesis of o-resveratal raw material constraints, synthesis of 5- substitute o-resveratal and piperine ethylamine, and the use of the two preparation of berberine hydrochloride, with raw materials readily available, mild reaction conditions, easy to operate, high chemical yield, low cost and other advantages.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 139-85-5